SEC Form 4 · accession 0001140361-15-001123
Protara Therapeutics, Inc. · TARA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Timothy P Noyes
Officer — President and CEO · Director
Period of report
Jan 7, 2015
Accepted (ET)
Jan 8, 2015 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001359931
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.61 | Jan 7, 2015 | A | 134,333 | A | — | Jan 6, 2025 | Common Stock | 134,333 | 134,333 | D |
Explanation of responses
- F1The shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments.